Fairmount Funds Management LLC, 10% Owner at Cogent Biosciences, Inc. (COGT), bought 800,000 shares at $12.00 ($9.6M) on 2023-06-09, disclosed to the SEC on 2023-06-13.
Open-market purchase of $9.6M COGT by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| Filing → |
| SYRE | SELL | 2026-06-23 | $399.7M | — | Filing → |
| VRDN | BUY | 2026-05-13 | $20.0M | — | Filing → |
| ZBIO | BUY | 2026-04-01 | $3.0M | — | Filing → |